Valganciclovir for the Suppression of Epstein-Barr Virus Replication

Epstein-Barr virus (EBV) causes infectious mononucleosis and can lead to lymphoproliferative diseases. We evaluated the effects of valganciclovir on oral EBV shedding in a randomized, double-blind, placebo-controlled study. Twenty-six men received oral valganciclovir or daily placebo for 8 weeks, fo...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Infect Dis
Autors principals: Yager, Jessica E, Magaret, Amalia S, Kuntz, Steven R, Selke, Stacy, Huang, Meei-Li, Corey, Lawrence, Casper, Corey, Wald, Anna
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2017
Matèries:
Brief Reports
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5854009/
https://ncbi.nlm.nih.gov/pubmed/28838145
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jix263
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars